13.02.2014 • NewsrenewablesRenewable EnergyEEG

EU Opens Proceedings Against German Energy Rebates

As expected, the European Commission has opened proceedings against Germany for granting special privileges to energy-intensive companies under the renewable energy act (EEG) and ordered that the federal government end the rebates by Dec. 18, 2014.

Under the German regulations, companies with high energy costs are exempted from a large proportion of the levies on utility bills to support renewable energy. This also includes firms generating their own on-site energy.

Currently, around 2,000 companies, including many in the chemical industry, profit from the regulations, thereby collectively saving an estimated €500 billion annually.

The country's new economics minister, the Social Democrat Sigmar Gabriel, has said in the past that German industry stands to lose competitiveness if required to pay the full renewables levy. However, in a meeting with the minister on Feb. 11, industry representatives said he had offered no concessions to affected companies.

According to the German Federal Office of Economics and Export Control, 2,098 companies will profit from the energy rebates in 2014, some 378 more than in 2013.

The German chemical industry association, VCI, has called on the government to scale back its aid to renewables, saying that the targets have been more than met, while at the same time the security of energy supply is threatened and costs are exploding.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.